Glenn Bubley
Physician · Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center
Credentials: · · · ·
History
- 1980–1982
Medical Oncology
- 1977–1980
Internal Medicine
Research
Journal of Clinical Oncology · 2008 · 1,931 citations
Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer
New England Journal of Medicine · 1995 · 1,019 citations
Cancer Research · 2006 · 883 citations
41 papers
- PK
21 papers
14 papers · 1 as a resident
11 papers · 1 as a resident
11 papers
- WD
11 papers
- WO
11 papers
11 papers · 4 as a resident
Grants
- 1999–2014
Eastern Cooperative Oncology Group
National Cancer Institute · U10
Contact PI · $139.4K · Beth Israel Deaconess Medical Center
- 1997–1999
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $180.8K · Beth Israel Deaconess Medical Center
- 1997–1999
Sequential/Additive Hormonal Therapy for Prostate Cancer
National Cancer Institute · R03
Contact PI · $167K · Beth Israel Deaconess Medical Center
- 1991–1996
Mechanisms of Platinum-Induced Mutagenesis
National Cancer Institute · R29
Contact PI · $590.4K · Beth Israel Deaconess Medical Center
Clinical trials
- 2014–2018
Enzalutamide + External Beam Rt For Prostate
Principal investigator · Completed · Phase 2
Dana-Farber Cancer Institute
- 2012–2016
BKM120+Abiraterone Acetate for Metastatic CRPC
Principal investigator · Terminated · Phase 1
Dana-Farber Cancer Institute
- 2009–2013
Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer
Principal investigator · Terminated · Phase 1, Phase 2
Dana-Farber Cancer Institute
- 2001–2011
Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer
Principal investigator · Completed · Phase 2
Beth Israel Deaconess Medical Center